TrialLeukemia2018

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.

H Goldschmidt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.